Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays

Journal of Medical Virology

Volumn 64, Issue 3, 2001, Pages 217-222

  De Mendoza, C ^a   Lu, W ^a   Machuca, A ^a   Sainz, M ^a   Castilla, J ^a   Soriano, V ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Antiretroviral therapy; HIV 1 group O; Quantitative assay; Viral load

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MALE; MEDICAL DECISION MAKING; PATIENT MONITORING; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; GENES, VIRAL; GENOTYPE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME; VARIATION (GENETICS); VIRAL LOAD; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034972734     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.1039     Document Type: Article

References (20)

1. Performance of a multiplex qualitative PCR LCx assay for detection of HIV-1 group M subtypes, group O and HIV-2
2. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1
3. Comparative evaluation of three assays for the quantitation of HIV type 1 RNA in plasma
4. HIV-1 group O sensitivity to antiretroviral drugs
5. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection
6. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients
7. Measurement of HIV type 1 plasma virus load based on reverse transcriptase (RT) activity: Evidence of variabilities in levels of virion-associated RT
8. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity
9. Reactivity and amplification efficiency of the NASBA HIV-1RNA amplification system with regard to different HIV-1 subtypes
10. Variability of HIV type 1 group O strains isolated from Cameroonian patients living in France
11. Use of the HIV virion as a universal standard for viral RNA quantitation by reverse transcription-linked polymerase chain reaction
12. Ultrasensitive HIV detection and quantitation by multi-target reverse transcription-linked PCR
13. Equivalent amplification of intrinsically variable nucleic acid sequence by multiple-primer induced overlapping amplification assay: Applications for universal detection and quantitation
14. Quantitative p24 antigenaemia for monitoring response to antiretroviral therapy in HIV-1 group O-infected patients
15. Impact of HIV type 1 subtype variation on viral quantitation
16. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of HIV type 1
17. Virological failure and adherence to antiretroviral therapy in HIV-infected patients
18. Extensive variation of HIV type 1 in vivo
19. Evaluation of the Nuclisens HIV-1 QT assay for quantitation of HIV type 1 RNA levels in plasma
20. First case of HIV-1 group O infection in Spain